Key result
Endovascular baroreflex amplification using the MobiusHD device is reviewed as a promising alternative treatment strategy for patients with resistant hypertension.
Why the study?
Endovascular baroreflex amplification provides an alternative treatment strategy for resistant hypertension using the MobiusHD device implanted in the internal carotid artery.
Endovascular baroreflex amplification using the MobiusHD device is an emerging alternative treatment strategy for resistant hypertension.
Supports hypothesis of benefit with MobiusHD in resistant hypertension; leaves open confirmation in randomized trials.
Endovascular baroreflex amplification is an alternative treatment strategy for patients with resistant hypertension. In endovascular baroreflex, the carotid baroreflex is activated by a MobiusHD® device (MD) which has been implanted in the internal carotid artery. This review will discuss the MD technology and mechanism of action and promising results in the first-in-human prospective study involving the use of the MD in patients with resistant hypertension.
No takes yet. Share an insight, caveat, or question.
Halim et al. (2020) conducted a review in Resistant hypertension. Endovascular baroreflex amplification (MobiusHD device) was evaluated. Endovascular baroreflex amplification using the MobiusHD device is reviewed as a promising alternative treatment strategy for patients with resistant hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: